• Profile
Close

APACHE-II score for anti-tuberculosis tolerance in critically ill patients: A retrospective study

BMC Infectious Diseases Feb 07, 2019

Qiu J, et al. - In this analysis, the status of anti-tuberculosis treatment in critically ill patients was investigated, and the value of APACHE-II score in guiding anti-tuberculosis treatment was explored. Researchers enrolled 320 patients (58 ± 22 years of age; 256 males), and drugs were withdrawn in 147 (45.9%). Independent factors associated with drug withdrawal comprised APACHE-II score > 18, COPD, and hemoglobin level. APACHE-II score had sensitivity, specificity, positive predictive value, and negative predictive value for predicting drug withdrawal of 59.2%, 61.8%, 56.9%, and 64.1%, respectively, at an optimal cutoff of 18.5. These findings suggested a possible predictive value of APACHE-II score > 18 points for patient tolerance of anti-tuberculosis treatment.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay